Bivalirudin/Prasugrel Versus Abciximab/Clopidogrel in Patients Presenting With STEMI

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 800 participants.

Also called NCT01158846

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 800 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT01158846
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Italy (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01158846. Non-randomized; no masking; primary purpose treatment. Start 2010-08 (registry gives no type); primary completion 2011-06 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Bivalirudin/Prasugrel Versus Abciximab/Clopidogrel in Patients Presenting With STEMI
Condition
ST-Elevation Myocardial Infarction
Intervention (Drug)
prasugrel/bivalirudin
Intervention (Drug)
clopidogrel/abciximab
Lead sponsor
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio (class: other)
Collaborator
Centro Cardiologico Monzino (class: other)
Collaborator
Azienda Ospedaliera Niguarda Cà Granda (class: other)
Collaborator
Istituto Clinico Humanitas (class: other)

Record details

Record id
cardio:ct-nct01158846
Content hash
41a5d53f40c4b5757ef78a8dfe80162e639fdf3e117e61567436f5a150d6550a